Rekvina Labs Allots 50.87 Lakh Shares in Preferential Issue

Rekvina Laboratories Ltd has approved the allotment of 50,87,750 equity shares on a preferential basis. This includes 46,27,750 shares issued for consideration other than cash, as part of the acquisition of 100% equity in Radiant Parenterals Limited. The remaining 4,60,000 shares were allotted for a cash consideration of ₹46,00,000. The acquisition of Radiant Parenterals Limited will make it a wholly-owned subsidiary of Rekvina Laboratories. The shares were issued at a premium, with a face value of ₹5 and an issue price of ₹10 per share.